how glp 1 medications are changing consumer behavior GLP-1s Reshaping – Sarah Hormachea GLP-1 Drugs and Consumer Preferences:

There are currently no licensed oral liquid GLP-1 formulations in the UK

Some people notice their weight dropping quickly in the first few weeks due to weight loss and appetite reduction, but its important to maintain realistic expectations on average, you will see around 1 to 2 pounds of weight loss per week after the initial phase

Concepts from notes: Truveta receives all clinical notes generated during patient care

In early 2026, Roche paid $100 million to secure a non-exclusive patent licence from Structures subsidiary Gasherbrum Bio, covering intellectual property relevant to CT-996, the oral GLP-1 compound Roche acquired through its $2.7 billion buyout of Carmot Therapeutics in late 2023